Sign in
BIO-B Stock Price, Chart, Stats & News
Bio-Rad Laboratories, Inc.
Save
7.64B
Market cap
50.52x
Current P/E
34.36x
Forward P/E
BIO-B chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 51.87% |
Operating margin | 8.87% |
Pretax margin | 38.54% |
Net margin | 29.42% |
Effective tax rate | 23.67% |
ROA | 7.18% |
ROE | 10.86% |
D/E | 0.21x |
Interest coverage ratio | 4.68x |
BIO-B valuation
P/E | 50.52x |
P/S | 2.77x |
P/B | 0.96x |
P/CF | 13.45x |
P/FCF | 19.12x |
P/OCF | 13.45x |
PEG | 0.04x |
EV multiple | 7.29x |
About
Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics.
Similar securities
Based on sector and market capitalization
Report issue